Medirom Healthcare Technologies (MRM) Cash & Current Investments (2019 - 2025)

Medirom Healthcare Technologies has reported Cash & Current Investments for 7 years, with the latest figure at $2.3 million in Q2 2025.

• For the quarter ending Q2 2025, Cash & Current Investments rose 239.46% year-over-year to $2.3 million; the trailing twelve-month figure through Jun 2025 stood at $2.3 million (up 239.46% YoY), and the FY2024 full-year result was $2.2 million, up 136.24% from the prior year.
• Cash & Current Investments for Q2 2025 stood at $2.3 million, up from $2.2 million in the prior quarter.
• The five-year high for Cash & Current Investments was $13.2 million in Q2 2021, with the low at $233356.0 in Q4 2021.
• Average Cash & Current Investments over 5 years is $3.7 million, with a median of $2.8 million recorded in 2022.
• Year-over-year, Cash & Current Investments jumped 1104.56% in 2022 and slumped 84.54% in 2024.
• Tracing MRM's Cash & Current Investments over 5 years: stood at $233356.0 in 2021, then soared by 1104.56% to $2.8 million in 2022, then surged by 52.1% to $4.3 million in 2023, then sank by 48.37% to $2.2 million in 2024, then increased by 5.07% to $2.3 million in 2025.
• The last three Cash & Current Investments figures came in at $2.3 million (Q2 2025), $2.2 million (Q4 2024), and $683162.4 (Q2 2024), per Business Quant data.

Peer Comparison